Literature DB >> 23073273

Long-term survival after hospitalization for acute heart failure--differences in prognosis of acutely decompensated chronic and new-onset acute heart failure.

Johan P E Lassus1, Krista Siirilä-Waris, Markku S Nieminen, Jukka Tolonen, Tuukka Tarvasmäki, Keijo Peuhkurinen, John Melin, Kari Pulkki, Veli-Pekka Harjola.   

Abstract

AIMS: To analyze the five-year mortality after hospitalization for acute heart failure (AHF) and compare predictors of prognosis in patients with and without a previous history of heart failure.
METHODS: Patients with AHF (n=620) from the prospective multicenter FINN-AKVA study were classified as acutely decompensated chronic heart failure (ADCHF) or de-novo AHF if no previous history of heart failure was present. Both all-cause mortality during five years of follow-up and prognostic factors were determined.
RESULTS: The overall mortality was 60.3% (n=374) at five years. ADCHF was associated with significantly poorer outcome compared to de-novo AHF; five-year mortality rate 75.6% vs. 44.4% (p<0.001). Initially, mortality was high (33.5% in ADCHF and 21.7% in de-novo AHF after 12 months), but in de-novo AHF the annual mortality declined markedly already after the first year. Compared to de-novo AHF, patients with ADCHF had an increased risk of death for several years after the index hospitalization. A previous history of heart failure was an independent predictor of five-year mortality (adjusted hazard ratio 1.8 (95% CI 1.4-2.2; p<0.001). Older age and impaired renal function were associated with adverse long-term prognosis in both ADCHF and de-novo AHF, while higher systolic blood pressure on admission predicted better outcome.
CONCLUSION: The long-term prognosis after hospitalization for AHF is poor, with a significantly different survival observed in patients with de-novo AHF compared to ADCHF. A previous history of heart failure is an independent predictor of five-year mortality. Distinction between ADCHF and de-novo AHF may improve our understanding of patients with AHF.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  95% CI; 95% confidence interval; ACEI/ARB; ACS; ADCHF; AHF; Acute heart failure; De-novo; HR; IQR; LVEF; Long-term prognosis; MDRD; Mortality; N-terminal pro B-type natriuretic peptide; NT-proBNP; SD; acute coronary syndrome; acute heart failure; acutely decompensated chronic heart failure; angiotensin converting enzyme inhibitor/angiotensin receptor blocker; eGFR; estimated glomerular filtration rate; hazard ratio; interquartile range; left ventricular ejection fraction; modified diet in renal disease; standard deviation

Mesh:

Year:  2012        PMID: 23073273     DOI: 10.1016/j.ijcard.2012.09.128

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  24 in total

1.  Mortality among patients with pleural effusion undergoing thoracentesis.

Authors:  Erin M DeBiasi; Margaret A Pisani; Terrence E Murphy; Katy Araujo; Anna Kookoolis; A Christine Argento; Jonathan Puchalski
Journal:  Eur Respir J       Date:  2015-04-02       Impact factor: 16.671

Review 2.  Therapeutic Advances in the Management of Acute Decompensated Heart Failure.

Authors:  Elena-Laura Antohi; Andrew P Ambrosy; Sean P Collins; Ali Ahmed; Vlad Anton Iliescu; Gad Cotter; Peter S Pang; Javed Butler; Ovidiu Chioncel
Journal:  Am J Ther       Date:  2019 Mar/Apr       Impact factor: 2.688

3.  The risk of death within 5 years of first hospital admission in older adults.

Authors:  Kieran L Quinn; Nathan M Stall; Zhan Yao; Therese A Stukel; Peter Cram; Allan S Detsky; Chaim M Bell
Journal:  CMAJ       Date:  2019-12-16       Impact factor: 8.262

4.  Short-term outcomes of heart failure patients with reduced and preserved ejection fraction after acute decompensation according to the final destination after emergency department care.

Authors:  Òscar Miró; V Íctor Gil; Francisco Javier Martín-Sánchez; Javier Jacob; Pablo Herrero; Aitor Alquézar; Lluís Llauger; Sira Aguiló; Gemma Martínez; José Ríos; Alberto Domínguez-Rodríguez; Veli-Pekka Harjola; Christian Müller; John Parissis; W Frank Peacock; Pere Llorens
Journal:  Clin Res Cardiol       Date:  2018-03-28       Impact factor: 5.460

5.  The midrange left ventricular ejection fraction (LVEF) is associated with higher all-cause mortality during the 1-year follow-up compared to preserved LVEF among real-world patients with acute heart failure: a single-center propensity score-matched analysis.

Authors:  Josip Anđelo Borovac; Katarina Novak; Josko Bozic; Duska Glavas
Journal:  Heart Vessels       Date:  2018-08-29       Impact factor: 2.037

6.  Etiological Peculiarities in Pediatric Heart Failure.

Authors:  Angela Butnariu; Gabriel Samasca
Journal:  Maedica (Bucur)       Date:  2015-09

7.  Association of heart failure duration with clinical prognosis in advanced heart failure.

Authors:  Atsushi Sugiura; Hideki Kitahara; Togo Iwahana; Noriko Suzuki; Sho Okada; Hideyuki Miyauchi; Yoshio Kobayashi; Nikos Werner
Journal:  Clin Res Cardiol       Date:  2019-06-27       Impact factor: 5.460

Review 8.  Evolving therapeutic strategies for patients hospitalized with new or worsening heart failure across the spectrum of left ventricular ejection fraction.

Authors:  John W Ostrominski; Muthiah Vaduganathan
Journal:  Clin Cardiol       Date:  2022-06       Impact factor: 3.287

Review 9.  Cardiohepatic syndrome: liver injury in decompensated heart failure.

Authors:  Said Laribi; Alexandre Mebazaa
Journal:  Curr Heart Fail Rep       Date:  2014-09

10.  Serum Individual Nonesterified Fatty Acids and Risk of Heart Failure in Older Adults.

Authors:  Luc Djousse; Mary L Biggs; Nirupa R Matthan; Joachim H Ix; Annette L Fitzpatrick; Irena King; Rozenn N Lemaitre; Barbara McKnight; Jorge R Kizer; Alice H Lichtenstein; Kenneth J Mukamal; David S Siscovick
Journal:  Cardiology       Date:  2021-02-25       Impact factor: 1.869

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.